| 摘要 |
The invention relates to the use of a beta -interferon. The beta -interferon is suitable for producing drugs for treating prostate cancer. The beta -interferon is administered to patients, whose PSA value (prostate specific antigen value) is increased in relation to preceding PSA values. |
